Profil
Aaron Vernon worked as VP-Global Supply Chain & Manufacturing at Sucampo Pharmaceuticals, Inc. and as VP-Global Technical Operations & Engineering at Autolus Therapeutics Plc.
He also worked as Vice President-Technical Operations at TCR2 Therapeutics, Inc. from 2021 to 2023.
Mr. Vernon completed his undergraduate degree at the University of Pennsylvania, his graduate degree at Rutgers State University of New Jersey, and his MBA at the University of Maryland.
Anciens postes connus de Aaron Vernon
| Sociétés | Poste | Fin |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | 01/01/2023 |
| SUCAMPO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| AUTOLUS THERAPEUTICS PLC | Corporate Officer/Principal | - |
Formation de Aaron Vernon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
















